Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil in Pediatric General Anesthesia
NCT01998165Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2013
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of remifentanil in general anesthesia, sponsored by Janssen Pharmaceutical. Started Nov 2013; status: completed.
02
Drugs
remifentanil
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT01998165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01998165.